CLS: Comments on Q2’22 Report and Issue Announcement - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

CLS: Comments on Q2’22 Report and Issue Announcement - Redeye

{newsItem.title}

Redeye provides its comments on CLS Q2’22 report. The report did not include any surprises, and we believe the second half of the year will be interesting for CLS. However, we also comment on yesterday’s rights issue announcement.

Länk till analysen i sin helhet: https://www.redeye.se/research/850573/cls-comments-on-q222-report-and-issue-announcement?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt